Jeff Yass’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$148K Buy
63,300
+47,700
+306% +$117K ﹤0.01% 12232
2026
Q2
$20.3K Sell
15,600
-19,900
-56% -$29K ﹤0.01% 13046
2026
Q1
$51.5K Buy
35,500
+8,000
+29% +$12.7K ﹤0.01% 12631
2025
Q4
$38K Sell
27,500
-2,400
-8% -$5.02K ﹤0.01% 11831
2025
Q3
$81.6K Buy
29,900
+14,200
+90% +$50.4K ﹤0.01% 11673
2025
Q2
$54.8K Buy
+15,700
New +$62K ﹤0.01% 12084
2023
Q1
– Sell
-48,100
Closed -$330K – 13469
2022
Q4
$330K Buy
+48,100
New +$227K ﹤0.01% 8860
2021
Q3
– Sell
-42,600
Closed -$682K – 13531
2021
Q2
$682K Buy
42,600
+10,300
+32% +$142K ﹤0.01% 8807
2021
Q1
$400K Buy
32,300
+13,700
+74% +$210K ﹤0.01% 9988
2020
Q4
$207K Buy
+18,600
New +$140K ﹤0.01% 9980

Other funds holding STIM

Jeff Yass's STIM Position: Q3 2026 in Review

Jeff Yass reduced its Neuronetics (STIM) stake by 53% in Q3 2026, selling an estimated $241K and leaving 87,632 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #11912.

Jeff Yass first reported a position in STIM in Q1 2021 and has held it in 18 quarters since. The position peaked at $2.8M in Q1 2025. 95 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Jeff Yass held 87,632 shares of Neuronetics worth $205K as of Q3 2026.
  • Jeff Yass sold 98,121 Neuronetics shares in Q3 2026, an estimated $241K.
  • Neuronetics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11912 holding.
  • Jeff Yass first reported a position in Neuronetics in Q1 2021 and has held it in 18 quarters since.
  • Jeff Yass's Neuronetics position peaked at $2.8M in Q1 2025.
  • 95 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.